Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflamm. Bowel Dis. 2022 Nov 02;28(11)1725-1736, M Chaparro, I Baston-Rey, E Fernández-Salgado, J González García, L Ramos, MT Diz-Lois Palomares, F Argüelles-Arias, E Iglesias Flores, M Cabello, S Rubio Iturria, A Núñez Ortiz, M Charro, D Ginard, C Dueñas Sadornil, O Merino Ochoa, D Busquets, E Iyo, A Gutiérrez Casbas, P Ramírez de la Piscina, MM Boscá-Watts, M Arroyo, MJ García, E Hinojosa, J Gordillo, P Martínez Montiel, B Velayos Jiménez, C Quílez Ivorra, JM Vázquez Morón, J María Huguet, Y González-Lama, AI Muñagorri Santos, VM Amo, MD Martín-Arranz, F Bermejo, J Martínez Cadilla, C Rubín de Célix, P Fradejas Salazar, AL San Román, N Jiménez, S García López, A Figuerola, I Jiménez, FJ Martínez Cerezo, C Taxonera, P Varela, R de Francisco, D Monfort, G Molina Arriero, A Hernández Camba, FJ García-Alonso, M Van Domselaar, R Pajares Villarroya, A Núñez, F Rodríguez Moranta, I Marín-Jiménez, V Robles Alonso, MDM Martín Rodríguez, P Camo-Monterde, I García Tercero, M Navarro Llavat, L Arias García, D Hervías Cruz, S Sulleiro, C Novella, E Vispo, M Barreiro-de Acosta, JP GisbertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.